Ketamine nasal spray can fight depression, suicidal thoughts: Study

The results of the study support nasal spray esketamine as a possible effective rapid treatment for depressive symptoms in patients assessed to be at imminent risk for suicide.

Published: 16th April 2018 12:14 PM  |   Last Updated: 16th April 2018 12:20 PM   |  A+A-

Image for representational purpose only.

By PTI

WASHINGTON: A novel nasal spray of ketamine - often misused as a party drug - can rapidly treat symptoms of major depression, and suicidal thoughts, a study has found.

The study, published in The American Journal of Psychiatry, compared an intranasal formulation of esketamine, part of the ketamine molecule, to a placebo for rapid treatment of symptoms of major depression, including suicidality, among individuals at imminent suicide risk.

The researchers at the Yale School of Medicine in the US involved 68 participants randomly assigned to one of two groups - either receiving esketamine or placebo twice a week for four weeks alongside standard treatment with antidepressants.

They looked at effects at four hours after first treatment, at 24 hours and at 25 days.

Researchers, including those from Janssen Research and Development, found a significant improvement in depression scores and decreased suicidal ideation in the esketamine group compared to the placebo group at four hours and at 24 hours.

The esketamine effects were not greater than the placebo at 25 days.

The measurement of suicide risk took into consideration both the patient's and clinician's perspectives.

The results of the study support nasal spray esketamine as a possible effective rapid treatment for depressive symptoms in patients assessed to be at imminent risk for suicide, researchers said.

Esketamine could be an important treatment to bridge the gap that exists because of the delayed effect of most common antidepressants.

Most antidepressants take four to six weeks to become fully effective.

The scientists caution that more research is needed on the potential for abuse of ketamine.

Stay up to date on all the latest Health news with The New Indian Express App. Download now

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.